The first new treatment for Alzheimer’s disease for nearly 20 years has been approved by regulators in the United States, paving the way for its use in the UK.
Aducanumab targets the underlying cause of Alzheimer’s, the most common form of dementia, rather than its symptoms.
Charities have welcomed the news of a new therapy for the condition.
But scientists are divided over its potential impact because of uncertainty over the trial results.
Please subscribe HERE http://bit.ly/1rbfUog
#BBCNews
PARIGI (FRANCIA) (ITALPRESS) – Alexander Zverev vince il Roland Garros 2026. Il tennista tedesco batte Flavio Cobolli nella finale del…
Nuovo malore per l’ex giocatore dell’InterODENSE (DANIMARCA) (ITALPRESS) – Un drammatico deja vu. A Odense, durante il secondo tempo dell’amichevole…
MONTE-CARLO (MONACO) (ITALPRESS) (ITALPRESS) – Andrea Kimi Antonelli ormai è inarrestabile. Il pilota della Mercedes domina incontrastato il Gran Premio…
ATENE (GRECIA) (XINHUA/ITALPRESS) – L’industria cantieristica cinese sta accelerando la sua transizione verso uno sviluppo più ecologico e intelligente, contribuendo…
Deputy Prime Minister David Lammy has told the US Vice President JD Vance "he was wrong" to say mass migration…